Phaeochromocytoma and paraganglioma (PPGL) are chromaffin cell tumours that require
timely diagnosis because of their potentially serious cardiovascular and sometimes life …

Pheochromocytoma and paraganglioma (PPGL) require prompt consideration and efficient
diagnosis and treatment to minimize associated morbidity and mortality. Once considered …

Simple and accurate monitoring of urinary dopamine (DA) concentration is significant, which
is helpful for the assessment or exclusion of catecholamine-producing tumors, such as …

Context Pheochromocytoma and sympathetic paraganglioma (PPGL) are rare
catecholamine-secreting tumors but recent studies suggest increasing incidence …

This article aims to review current concepts in diagnosing and managing
pheochromocytoma and paraganglioma (PPGL). Personalized genetic testing is vital, as 40 …

Objective Hypertension and symptoms of catecholamine excess are features of
pheochromocytomas and paragangliomas (PPGLs). This prospective observational cohort …

Pheochromocytoma/paraganglioma (PPGL) are neuroendocrine tumors that frequently
produce and release catecholamines. Catecholamine excess can manifest in several …

Although many endocrine diseases can be associated with acquired cardiomyopathy and
heart failure, conditions except hypothyroidism, hyperthyroidism, phaeochromocytoma …

Pheochromocytomas (PCCs) are rare neuroendocrine tumors. About 80% to 85% of these
cancers arise from chromaffin cells residing in the adrenal medulla. The remaining 15% to …

Abstract Purpose of Review Pheochromocytomas and paragangliomas (PPGLs) are
uncommon catecholamine-producing neuroendocrine neoplasms that usually present with …